Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
Henricus A.M. Mutsaers, Rikke Nørregaard
Kidney Res Clin Pract. 2022;41(1):4-13.   Published online 2022 Jan 13     DOI: https://doi.org/10.23876/j.krcp.21.222
Citations to this article as recorded by Crossref logo
An animal-free preclinical drug screening platform based on human precision-cut kidney slices
Henricus A. M. Mutsaers, Michael Schou Jensen, Jean-Claude Kresse, Stine Julie Tingskov, Mia Gebauer Madsen, Rikke Nørregaard
BMC Research Notes.2023;[Epub]     CrossRef
Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis
Chan Ho Kim, Hye-Young Kang, Gyuri Kim, Jimin Park, Bo Young Nam, Jung Tak Park, Seung Hyeok Han, Shin-Wook Kang, Tae-Hyun Yoo
Frontiers in Pharmacology.2023;[Epub]     CrossRef
Further Characterization of Multi-Organ DEARE and Protection by 16,16 Dimethyl Prostaglandin E2 in a Mouse Model of the Hematopoietic Acute Radiation Syndrome
Tong Wu, Louis M. Pelus, P. Artur Plett, Carol H. Sampson, Hui Lin Chua, Alexa Fisher, Hailin Feng, Liqiong Liu, Hongge Li, Miguel Ortiz, Supriya Chittajallu, Qianyi Luo, Ashay D. Bhatwadekar, Timothy B. Meyer, Xin Zhang, Daohong Zhou, Kathryn D. Fischer,
Radiation Research.2023;[Epub]     CrossRef
Repurposing small molecules for nephronophthisis and related renal ciliopathies
Alexandre Benmerah, Luis Briseño-Roa, Jean-Philippe Annereau, Sophie Saunier
Kidney International.2023; 104(2): 245.     CrossRef
Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor
Hung-Jin Huang, Yu-Hsuan Lee, Li-Chin Sung, Yi-Jie Chen, Yu-Jhe Chiu, Hui-Wen Chiu, Cai-Mei Zheng
Computational and Structural Biotechnology Journal.2023; 21: 3490.     CrossRef
Identified and potential internalization signals involved in trafficking and regulation of Na+/K+ ATPase activity
Rawad Hodeify, Sawsan Kreydiyyeh, Leen Mohammad Jamal Zaid
Molecular and Cellular Biochemistry.2023;[Epub]     CrossRef
Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
Rikke Nørregaard, Henricus A. M. Mutsaers, Jørgen Frøkiær, Tae-Hwan Kwon
Physiological Reviews.2023; 103(4): 2847.     CrossRef
Development of renal fibrosis in patients with chronic kidney disease: Mechanisms, biomarkers, and clinical implications
L. Denova
Ukrainian Journal of Nephrology and Dialysis.2023; (3(79)): 54.     CrossRef
EP1 receptor antagonism mitigates early and late stage renal fibrosis
Jean‐Claude Kresse, Henricus A. M. Mutsaers, Michael Schou Jensen, Stine Julie Tingskov, Mia Gebauer Madsen, Lene N. Nejsum, Helle Prætorius, Rikke Nørregaard
Acta Physiologica.2022;[Epub]     CrossRef
Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
Xu Guan, Yong Liu, Wang Xin, Shaozong Qin, Shuiqin Gong, Tangli Xiao, Daohai Zhang, Yan Li, Jiachuan Xiong, Ke Yang, Ting He, Jinghong Zhao, Yinghui Huang
Frontiers in Pharmacology.2022;[Epub]     CrossRef
TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
Cheol Ho Park, Tae-Hyun Yoo
Pharmaceuticals.2022; 15(12): 1485.     CrossRef